Kidney organoids designed with the same mutation as that present in Fabry disease can help investigators better understand how the disease functions, authors suggested. A new report makes the case ...
MIcro cap Protalix BioTherapeutics (NYSE:PLX) perks up 7% premarket on robust volume in response to its announcement of positive preclinical data on PRX-102 (pegunigalsidase alfa). In mouse models of ...
Fabry disease is a metabolic disease characterized by a deficiency in the lysosomal α-galactosidase enzyme caused by mutations in the GLA gene. This leads to substrate accumulation in the lysosomes, ...
Induced pluripotent stem (iPS) cells have a great impact on biology and medicine, and they are expected to improve regenerative medicine. Since 2014 when a sheet of retinal pigment epithelial cells ...
Fabry disease (MIM 301500) is a genetic disorder resulting from the deficient activity of lysosomal hydrolase α-galactosidase (GLA; EC 3. 2.1.22). 1 The enzymatic defect causes the progressive ...
Induced pluripotent stem (iPS) cells have a great impact on biology and medicine, and they are expected to improve regenerative medicine. Since 2014 when a sheet of retinal pigment epithelial cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback